The 17th annual Western Stroke Conference will occur on November 28th 2015 at the Rosewood Hotel in Vancouver, BC. Topics will include stroke prevention, newer oral anticoagulants, interventional stroke treatment, stroke neuroimaging, carotid disease management, minor stroke/TIA, case studies and “what’s new in stroke”. For more information: www.westernstrokeconference.com For registration: https://events.ubccpd.ca/website/index/110469
VSP has secured a pilot research grant from Boehringer-Ingleheim Canada to conduct PROPHECY: prospective validation of holter monitor predictors of paroxysmal atrial fibrillation.
The VSP is now actively recruiting for DATAS-II: Dabigatran following Transient ischemic attack and minor Stroke. The trial is funded by CIHR. For more information visit: https://clinicaltrials.gov/ct2/show/NCT02295826
The VSP is now actively recruiting for NAVIGATE-ESUS: Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients with Recent Embolic Stroke of Undetermined Source (ESUS). The trial is funded by Bayer. For more information visit: https://clinicaltrials.gov/ct2/show/NCT02313909
The VSP is now actively recruiting for FRONTIER: Field Randomization of NA-1 Therapy in Early Responders. The trial is funded by NoNo Inc. For more information visit: https://clinicaltrials.gov/ct2/show/NCT02315443